Novartis sees different drug pricing models: CEO in NZZ am Sonntag

ZURICH (Reuters) - Drug companies have taken too great a share of the benefits of new drug treatments but are moving to different models involving sharing more with health systems and insurers, the head of Swiss-based Novartis was quoted saying on Sunday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro